Literature DB >> 33224751

A new method of culturing rat bone marrow endothelial progenitor cells in vitro.

Zhaohong Kong1, Meixin Chen2, Jian Jiang1, Jiang Zhu3, Yumin Liu2.   

Abstract

BACKGROUND: Endothelial progenitor cells (EPCs) play an important role in the re-endothelialization of ischemic cerebrovascular disease. However, the current acquisition method has some deficiencies. This study aimed to design a new and practical method for obtaining EPCs.
METHODS: Bone marrow was obtained autologously from the right tibia of living rats. Briefly, the right tibia bone was carefully exposed and two holes (1 mm in diameter) were made in the tuberosity and lower one-third of the tibia, respectively. A PE-50 catheter and syringe (5 mL) were inserted through the holes to aspirate the bone marrow. Bone marrow mononuclear cells (BMMCs) were isolated by density-gradient centrifugation with Ficoll and counted. Adherent cell culture continued for 2 weeks, and the medium was replaced every 3 days.
RESULTS: During the first days of culture, adherent cells formed a monolayer, consisting predominantly of small-sized cells. Single large cells with endothelial morphology were observed. On day 4, the nonadherent cells were removed, and the adherent cells were left for further culture. On day 6-7, a proliferating population of round cells formed clusters in the culture chamber, and morphological analysis revealed a homogeneous population of colony-forming units (CFUs). Large, flat cells with endothelial morphology sprouted from the CFUs, which had nearly disappeared by day 14 of culture. The adherent cells were positive for CD133 and vascular endothelial growth factor receptor 2 (VEGFR2), internalized acetylated low-density lipoprotein, and bound ulex europaeus-agglutinin-I, but were negative for CD45, which correlated with the endothelial morphology and ability to form capillaries of EPCs.
CONCLUSIONS: Our results are direct evidence that mononuclear cells (MCS) from living rat bone marrow can be used to culture EPCs in vitro under certain culture conditions, providing a new method for the further study of autologous EPC transplantation. 2020 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Bone marrow; cell culture; endothelial progenitor cells (EPCs); rats

Year:  2020        PMID: 33224751      PMCID: PMC7666940          DOI: 10.21037/cdt-20-536

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  29 in total

Review 1.  Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization.

Authors:  George E Davis; Donald R Senger
Journal:  Circ Res       Date:  2005-11-25       Impact factor: 17.367

2.  Vascular wall resident progenitor cells: a source for postnatal vasculogenesis.

Authors:  Elvin Zengin; Fariba Chalajour; Ursula M Gehling; Wulf D Ito; Hendrik Treede; Heidrun Lauke; Joachim Weil; Hermann Reichenspurner; Nerbil Kilic; Süleyman Ergün
Journal:  Development       Date:  2006-03-08       Impact factor: 6.868

Review 3.  Tissue regeneration using endothelial colony-forming cells: promising cells for vascular repair.

Authors:  Kimihiko Banno; Mervin C Yoder
Journal:  Pediatr Res       Date:  2017-10-18       Impact factor: 3.756

4.  Effects of exercise on endothelial progenitor cells in patients with cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Suiane L Cavalcante; Susana Lopes; Lucimere Bohn; Iván Cavero-Redondo; Celia Álvarez-Bueno; Sofia Viamonte; Mário Santos; José Oliveira; Fernando Ribeiro
Journal:  Rev Port Cardiol (Engl Ed)       Date:  2020-02-07

Review 5.  Endothelial progenitor cells: Potential novel therapeutics for ischaemic stroke.

Authors:  Ulvi Bayraktutan
Journal:  Pharmacol Res       Date:  2019-04-17       Impact factor: 7.658

6.  Endothelial progenitor cells improve functional recovery in focal cerebral ischemia of rat by promoting angiogenesis via VEGF.

Authors:  Zhaohong Kong; Yan Hong; Jiang Zhu; Xin Cheng; Yumin Liu
Journal:  J Clin Neurosci       Date:  2018-07-21       Impact factor: 1.961

7.  Transcatheter Arterial Infusion of Autologous CD133(+) Cells for Diabetic Peripheral Artery Disease.

Authors:  Xiaoping Zhang; Weishuai Lian; Wensheng Lou; Shilong Han; Chenhui Lu; Keqiang Zuo; Haobo Su; Jichong Xu; Chuanwu Cao; Tao Tang; Zhongzhi Jia; Tao Jin; Georges Uzan; Jianping Gu; Maoquan Li
Journal:  Stem Cells Int       Date:  2016-02-14       Impact factor: 5.443

8.  Preclinical Evaluation and Optimization of a Cell Therapy Using Human Cord Blood-Derived Endothelial Colony-Forming Cells for Ischemic Retinopathies.

Authors:  Emma Reid; Jasenka Guduric-Fuchs; Christina L O'Neill; Lynsey-Dawn Allen; Sarah E J Chambers; Alan W Stitt; Reinhold J Medina
Journal:  Stem Cells Transl Med       Date:  2017-11-22       Impact factor: 6.940

9.  Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction.

Authors:  Ziwen Li; Emmanouil G Solomonidis; Marco Meloni; Richard S Taylor; Rodger Duffin; Ross Dobie; Marlene S Magalhaes; Beth E P Henderson; Pieter A Louwe; Gabriela D'Amico; Kairbaan M Hodivala-Dilke; Ajay M Shah; Nicholas L Mills; Benjamin D Simons; Gillian A Gray; Neil C Henderson; Andrew H Baker; Mairi Brittan
Journal:  Eur Heart J       Date:  2019-08-07       Impact factor: 29.983

10.  Differentiation of Rat bone marrow Mesenchymal stem cells into Adipocytes and Cardiomyocytes after treatment with platelet lysate.

Authors:  Farshad Homayouni Moghadam; Tahereh Tayebi; Kazem Barzegar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-01-01
View more
  1 in total

Review 1.  Regulation of endothelial progenitor cell functions during hyperglycemia: new therapeutic targets in diabetic wound healing.

Authors:  Gui Wan; Yangyang Chen; Jing Chen; Chengqi Yan; Cheng Wang; Wenqing Li; Renqun Mao; Hans-Günther Machens; Xiaofan Yang; Zhenbing Chen
Journal:  J Mol Med (Berl)       Date:  2022-01-08       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.